News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Erman Akkus: A very useful comprehensive review for daily practice
Photo taken from: Erman Akkus/X
Jan 30, 2024, 20:10

Erman Akkus: A very useful comprehensive review for daily practice

Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter:

“Metastatic RCC, IO(+TKI) > Renal toxicities

  • A very useful comprehensive review for daily practice
  • Therapy management of immune-based combinations in patients with CKD, on dialysis, or transplanted, as well as their renal toxicities”

Erman Akkus: A very useful comprehensive review for daily practice

Proceed to the article.
Source: Erman Akkus/X

cancer Erman Akkus OncoDaily Oncology Research
Special Coverage
Blog
Mar 31, 2025, 06:10
The lung cancer patient advocacy sessions at the ELCC 2025 were standout events - Lung Cancer Europe
Insight
Mar 31, 2025, 06:04
Yan Leyfman: Expanding Antibody Therapeutics with TCR Mimicry 
Blog
Mar 31, 2025, 05:50
Jennifer Bires: Proud to speak on AI and mental health at NCCS Cancer Advocacy’s Spring 2025 Cancer Policy Roundtable
Insight
Mar 31, 2025, 05:03
Jarushka Naidoo: My ELCC 2025 Top 3 - MARIPOSA, KRYSTAL7 and Deescalation trials
Blog
Mar 31, 2025, 04:59
Michael Sapienza: Federal funding for cancer and other disease research has been cut by more than $1 billion
Blog
Mar 31, 2025, 04:45
Amil Družić: Excited to be part of the upcoming Young Cancer Professionals Roundtable
Blog
Mar 31, 2025, 03:27
Inside Cancer Careers Podcast Concluding – Thank You to our guests and listeners for two incredible years: Train at NCI
Blog
Mar 31, 2025, 02:59
Ariana Znaor: Consultation period for International Classification of Diseases for Oncology, 4th Edition is extended
Blog
Mar 31, 2025, 02:16
Peter Pisters: Delighted to serve as keynote speaker at Opportunity Austin's quarterly meeting
Blog
Mar 30, 2025, 23:21
Sachin H. Jain: How has "expert bias" mislead you in your work?
Blog
Mar 30, 2025, 22:48
HESI THRIVE 2025 Seed Grant Program - Funding Opportunity for Innovative Cancer Research
Insight
Mar 30, 2025, 21:29
Bishoy Morris Faltas: AI model that predicts response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer